Once You Have Been Treated, Then What?

Once You Have Been Treated, Then What?
Hormone follow-up by measuring the level of human chorionic gonadotropin (hCG) in the blood continues until the hormone level is normal for three weeks, then should continue monthly for 12 months (24 months or patients with Stage IV disease). During that time the patient should avoid pregnancy. Women who conceive within 12 months of completing chemotherapy have an increased risk of miscarriage, particularly if they have received multiple chemotherapeutic agents. If pregnancy occurs before follow-up is complete, tumor relapse may be difficult to detect and diagnosis of relapse may be delayed.

The chemotherapy used for the treatment of malignant GTD is generally well tolerated without long-term side effects with two exceptions: 1) the use of multi-agent chemotherapy is associated with an earlier menopause, and 2) women with high-risk GTN who require multi-agent chemotherapy which includes a drug called etoposide and survive for more than 25 years should be advised that they may be at increased risk of developing secondary tumors, particularly acute myeloid leukemia, colon cancer, melanoma and breast cancer.

Spotlight

Check out this Women Magazine/aWomensheath.com page on gynecologic cancers, featuring our Listen, Learn, Act message and an article by National Race Surgeons Team Captain Linda Duska, M.D.

Awareness

This year’s GCAM awareness is focused on the important link between obesity and endometrial cancer. Check out the new toolkit to learn more.

Research

Prize applications are due on October 8, 2014. The Foundation for Women’s Cancer is pleased to share its 2014-2015 Research Grants and Awards booklet.

Education

The next Gynecologic Cancer Survivors Course will be Saturday, Oct. 11, 2014 in West Bloomfield, MI. For more information on educational events and courses, click here.